Jake Xia
Direktor/Vorstandsmitglied bei Hangzhou Qihan Biotech Co., Ltd.
Profil
Ji Qing Xia is currently a Director at Hangzhou Qihan Biotech Co., Ltd.
Prior to this, he held positions as Managing Director & Chief Risk Officer at Harvard Management Co., Inc., Vice President at Salomon Brothers, and Principal at Morgan Stanley Capital Partners (Private Equity).
He received his undergraduate degree from Peking University, his doctorate from Massachusetts Institute of Technology, and his graduate degree from Northeastern University.
Aktive Positionen von Jake Xia
| Unternehmen | Position | Beginn |
|---|---|---|
Hangzhou Qihan Biotech Co., Ltd.
 Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jake Xia
| Unternehmen | Position | Ende |
|---|---|---|
| Salomon Brothers | Corporate Officer/Principal | - |
Morgan Stanley Capital Partners (Private Equity)
 Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Corporate Officer/Principal | - |
Ausbildung von Jake Xia
| Massachusetts Institute of Technology | Doctorate Degree |
| Northeastern University | Graduate Degree |
| Peking University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Morgan Stanley Capital Partners (Private Equity)
Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Finance |
| Salomon Brothers | Finance |
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Health Services |
